From Stanford Scope blog: “Proteomics allows researchers to identify existing drugs to treat rare eye disease”
Science Springs,
Stanford…
Stanford…
In the past, treatment for a very rare genetic eye condition called neovascular inflammatory vitreoretinopathy, or NIV, was…